|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Share-based compensation expense | |||||
| Amortization of premium and accretion of discounts on short-term investments, net | |||||
| Depreciation expense | |||||
| Non-cash interest expense | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Operating lease right-of-use and other long-term assets | |||||
| Other long-term liabilities | |||||
| Contract liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Net cash (used in) provided by operating activities | |||||
| Investing Activities | |||||
| Purchases of short-term investments | |||||
| Maturities of short-term investments | |||||
| Purchases of property and equipment | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing Activities | |||||
| Proceeds from issuance of stock under equity plans | |||||
| Proceeds from issuances of common stock and pre-funded warrants, net of offering costs | |||||
| Net cash provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flow information: | |||||
| Interest paid | |||||
Loading...